Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2008
12/02/2008US7459151 Phosphate-binding polymers for oral administration
12/02/2008US7459146 Nanoparticles; administering drugs; mixture with excipients, propellants; stability; respiratory system disorders
12/02/2008US7459142 High viscosity embolizing compositions comprising prepolymers
12/02/2008US7458982 Photokinetic delivery of biologically active substances using pulsed incoherent light
12/02/2008US7458965 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method
12/02/2008US7458849 Coaxial connector having detachable locking sleeve
12/02/2008US7458374 Method and apparatus for vaporizing a compound
12/02/2008CA2610819A1 Particles in a capsule
12/02/2008CA2515946C Use of palonosetron treating post-operative nausea and vomiting
12/02/2008CA2492417C Formulation for menopausal women
12/02/2008CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/02/2008CA2447354C Method of forming an aerosol for inhalation delivery
12/02/2008CA2433812C A method for producing tablets from plant extracts
12/02/2008CA2433283C Chewing gums and related products that provide breath freshening characteristics
12/02/2008CA2397404C Micronized freeze-dried particles
12/02/2008CA2396111C Substances for use in treating psoriasis
12/02/2008CA2381203C Formulations for treating or preventing mucositis
12/02/2008CA2370294C Haze-free cellulose ether capsules and process for making
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
12/02/2008CA2356120C Intraoral adhesive preparation
12/02/2008CA2352552C Treatment of erectile dysfunction
12/02/2008CA2350838C Controlled release system for delivering therapeutic agents into the inner ear
12/02/2008CA2346631C Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media
12/02/2008CA2345773C Buffered resorbable internal fixation devices and methods for making material therefore
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2341624C Stable spray-dried protein formulations
12/02/2008CA2340224C Nimesulide containing topical pharmaceutical compositions
12/02/2008CA2338337C Foamable formulation and foam
12/02/2008CA2335485C Oregano for the treatment of internal parasites and protozoa
12/02/2008CA2335179C Tablet and process for making the same
12/02/2008CA2306371C Use of flunarizine for the topical treatment of glaucoma
12/02/2008CA2263568C Methods for diagnostic imaging using a contrast agent and a renal vasodilator
12/02/2008CA2172507C Methods and compositions for microencapsulation of antigens for use as vaccines
12/02/2008CA2136434C Erythropoietin drug delivery system
12/01/2008CA2632958A1 Patch and patch preparation
11/2008
11/27/2008WO2008144730A2 Stable pharmaceutical formulation for a dpp-iv inhibitor
11/27/2008WO2008144690A2 Compositions and methods for enhancing active agent absorption
11/27/2008WO2008144565A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
11/27/2008WO2008144355A2 Stable, self-microemulsifying fenofibrate compositions
11/27/2008WO2008144185A2 Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
11/27/2008WO2008144137A1 Therapeutic compositons for targeted vessel delivery
11/27/2008WO2008143992A2 Improved depot formulations
11/27/2008WO2008143906A2 Hypercompressed particles for controlled release of ophthalmic medications
11/27/2008WO2008143812A2 Biologic devices for hemostasis
11/27/2008WO2008143705A2 Methods and compositions for rapid inactivation of proteins
11/27/2008WO2008143682A1 Colored esmolol concentrate
11/27/2008WO2008143553A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity
11/27/2008WO2008143380A1 Composition for injection including propofol and method of preparing the same
11/27/2008WO2008143241A1 Method for producing pharmaceutical tablet
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008143239A1 Crystalline micropowder particles
11/27/2008WO2008142896A1 Poultice and process for producing the poultice
11/27/2008WO2008142637A1 Large coacervated capsules
11/27/2008WO2008142627A2 Multilayered modified release formulation comprising amoxicillin and clavulanate
11/27/2008WO2008142572A2 Controlled release tablet formulation containing magnesium aluminometasilicate
11/27/2008WO2008142231A2 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008WO2008142158A2 Hydrogel implant for sensing metabolites in body tissue
11/27/2008WO2008142153A1 An extended-release composition comprising a somatostatin derivative in microparticles
11/27/2008WO2008142090A1 Self-emulsifying formulation of tipranavir for oral administration
11/27/2008WO2008141954A1 Magazine for cylindrical vessels
11/27/2008WO2008141888A1 Oral dosage form providing fast absorption of drug
11/27/2008WO2008141751A2 Pharmaceutical compositions comprising oxcarbazepine
11/27/2008WO2008141570A1 A composition for improving quality of fetus, preventing and treating birth defects
11/27/2008WO2008141496A1 Sustained-release system for epo and gm-csf
11/27/2008WO2008141368A1 Combination laxative compositions comprising a colonic stimulant and a bulking laxative
11/27/2008WO2008124639A3 Poly (amino acid) targeting moieties
11/27/2008WO2008120181A3 A method of producing fast dissolving tablets
11/27/2008WO2008109031A8 Liposome carriers for in vivo delivery of fullerenes
11/27/2008WO2008106571A3 Sustained release parenteral formulations of buprenorphine
11/27/2008WO2008106503A3 Discrete size and shape specific pharmaceutical organic nanoparticles
11/27/2008WO2008101723A3 Pharmaceutical composition containing a cholesterol absorption inhibitor
11/27/2008WO2008101001A3 Three dimensional cell culture construct and apparatus for its making
11/27/2008WO2008099016A3 Method for stabilising blood plasma components in a lyophilisate
11/27/2008WO2008096804A8 Eye drop preparation comprising latanoprost
11/27/2008WO2008095144A3 Controlled release of actives in skin
11/27/2008WO2008094693A8 Compositions for aerosolization of highly conductive solutions
11/27/2008WO2008088394A3 Anionic latex as a carrier for bioactive ingredients
11/27/2008WO2008085765A3 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
11/27/2008WO2008085691A3 Multifunctional supramolecular hydrogels as biomaterials
11/27/2008WO2008083192A3 Methods and formulations for improved bioavailability of antiprogestins
11/27/2008WO2008082563A3 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
11/27/2008WO2008080037A3 Carotenoids of enhanced bioavailability
11/27/2008WO2008075191A3 Gas-filled microvesicles with targeting ligand in respect of fc-region of an antibody or therapeutic agent
11/27/2008WO2008073614A3 Composition and method for enhancing skin cell growth, proliferation and repair
11/27/2008WO2008071573A3 Powder formulation for valganciclovir
11/27/2008WO2008064092A3 Devices, systems and methods for medicament delivery
11/27/2008WO2008062320A3 Extended release formulations of a proton pump inhibitor
11/27/2008WO2008061014A9 Self-assembling peptide amphiphiles for tissue engineering
11/27/2008WO2008054772A3 Implantable elastomeric caprolactone depot compositions and uses thereof
11/27/2008WO2008053432A3 Chromophore formulations for use in the laser welding of biological tissues
11/27/2008WO2008039472A3 Stabilizing compositions for antibiotics and methods of use
11/27/2008WO2008036299A3 Edible water-soluble film containing a foam reducing flavoring agent
11/27/2008WO2008028047A3 Bioadhesive film drug delivery system
11/27/2008WO2008027340A3 Topical ophthalmic formulations
11/27/2008WO2008016602A3 Free base gacyclidine nanoparticles
11/27/2008WO2008008373A3 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
11/27/2008WO2007143158A3 Sustained release pharmaceutical formulation comprising phenylephrine
11/27/2008WO2007124302A3 Bone graft composition
11/27/2008WO2007121949A8 Transdermal delivery system comprising sufentanil and its analogues
11/27/2008WO2007117550A3 Methods for coacervation induced liposomal encapsulation and formulations thereof
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 2991